Summary: Prostate Cancer with Metastases to the bone
Inclusion Criteria:
- Men 18 years or older with histologically confirmed prostate cancer
- Current or prior radiographic evidence of at least 1 bone metastasis
- Documented rise in PSA on hormone therapy
- Testosterone level < 50 ng/dl
Exclusion Criteria:
- Current or prior oral or IV Bisphosphonate use
- Brain Metastases
- Known history of 2nd malignancy within the past 3 years, except basal cell carcinoma
- Osteomecrosis/osteomyelitis of the jaw
For more information, contact:
AdvanceMed Research
2 Princess Road, Suite J
Lawrenceville, NJ 08648
Telephone: 609-895-0735
Fill out our Volunteer Form to receive information on how to participate in one of our clinical trials.
Current Studies
Overactive Bladder
• Botox for Bladder Incontinence & Frequency
• Is Overactive Bladder a Part of Your Life?
• Nocturia - Waking Up at Night to Urinate
• Women, Overactive Bladder (OAB)
• Overactive Bladder with Urgency
• Single Bladder Instillation for OAB
• Overactive Bladder No Placebo
• Non-invasive Neurostimulator for OAB
• Topical Gel for Treatment of OAB
• Stress Urinary Incontinence
Erectile Dysfunction
Low Testosterone
Prostate Problems
• BPH
• BPH
Prostate Cancer
• Prostate Cancer requiring Hormone Therapy
• Prevention of Metastatic Disease
• Prostate Cancer with Metastatic Disease
Bladder Cancer
• Intravesical Treatment of non-Invasive Bladder Cancer
• Recurrent Bladder Cancer after BCG Treatment
Women's Health Issues
• Decreased Sexual Desire
Neurological Health Issues
• Parkinson's Disease Movement/Balance